IGF1R and ovarian cancer: Therefore, to examine the hypothesis that a quantitative balance between the levels of different components of the IGF system (i.e., IGF1, IGFBPs, and IGF1R) determines cellular response and impacts sensitivity to anti-IGF therapies, we experimentally examined ovarian cancer cell proliferation and cellular mechanisms that regulate IGF1 availability.